GL1X · GenesisL1 explorer

Research workbench

Human antibody S1V2-83 in complex with the influenza hemagglutinin head domain of A/MOSCOW/10/1999(H3N2)

Analyse Human antibody S1V2-83 in complex with the influenza hemagglutinin head domain… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6XPZ
Type
protein
Length
1,425 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hemagglutinin; Antibody S1V2-83 heavy chain; Antibody S1V2-83 light chain
UniProt
Q1NZ37
Ligands
NAG, BMA
Pockets
12 · best druggability 0.69

Structure

x-ray diffraction · 4 distinct chains · 9% helix, 40% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHemagglutininprotein26812% helix, 36% strandQ1NZ37
DHemagglutininprotein26912% helix, 34% strandQ1NZ37
B, EAntibody S1V2-83 heavy chainprotein2336% helix, 48% strand—
C, FAntibody S1V2-83 light chainprotein2116% helix, 46% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 10 copies · chains A, D, B
  • BMA · beta-D-mannopyranose · sugar · 3 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18670.690.7573empty
24040.570.7546empty
33360.560.7551empty
41090.490.8026empty
5770.390.7717empty

Interfaces

8 interfaces between chains.

  • B–C · 2061 Ų buried · 20 hydrogen bonds · protein-protein
  • E–F · 2022 Ų buried · 18 hydrogen bonds · protein-protein
  • D–E · 677 Ų buried · 7 hydrogen bonds · protein-protein
  • A–B · 654 Ų buried · 9 hydrogen bonds · protein-protein
  • D–B · 288 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 16 disulfide, 6 glycan (disulfide, N-glycosylation).

Compared structures

  • 6XPZ · Human antibody S1V2-83 in complex with the influenza hemagglutinin head domain of… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.